On the contrary, the occurrence of colon cancer is inhibited by DCA, which could restore the expression of NALP1, indicating that NALP1 is a potential therapeutic marker for colorectal carcinoma (17, 18). This evidence concerns the gene NLRP1 and colonic neoplasm.